BATH ONCOLOGY LTD
🏛️Establishedactive
11278431 · ltd · incorporated 2018-03-27
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Mar 2026
Net worth
£504.6k
book net assets
Opportunity
72/100
Strong
What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
PursueStrong opportunity: asset-holding vehicle with strong profile and bankable structure.
Opportunity 72/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
20 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
72/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
65
Adequate — check latest filings for context.
Acquirability
55
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Positive net assets
Net assets £504,561
Net assets shrinking
Down £123,005 YoY
Key financials
2 years extracted from filed iXBRL accountsCash
—
Net Worth
£505k
↓ 20% YoY
Current Assets
£598k
↓ 16% YoY
Current Liabilities
—
Hover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Total assets | £505.8k | £628.8k |
| Current assets | £598.1k | £714.8k |
| Net assets | £504.6k | £627.6k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
🔒Filing-note intelligence
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Last 30 days
1
filing
- • 1 accounts
Last 90 days
1
filing
- • 1 accounts
Last 180 days
2
filings
- • 1 accounts
- • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (15 events)Click to expand
- 2026-06-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-08-07📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-09-23📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-11-14📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-11-14📄change-person-director-company-with-change-dateofficers · CH01
- 2023-08-02📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-12-28📄legacymiscellaneous · RPCH01
- 2022-11-21📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-07-15📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-09-18📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-06-10📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-03-27🏢Company incorporatedAs BATH ONCOLOGY LTD
- 2018-03-27➕BERESFORD, Mark, Professor appointeddirector
- 2018-03-27➕BERESFORD, Sasha appointeddirector
- 2018-03-27📄incorporation-companyincorporation · NEWINC
Owner dependency
71/100
High — earn-out structure requiredMaterial founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
FACTORS
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
- +No director turnover: Company is 8 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
36/100
Weak signalLimited succession signal. Not a near-term off-market candidate.
SIGNALS
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Professor Mark Beresford Individual · British · DOB 04/1971 · age 55 | 25–50% | — | 25-50% shares | 27/03/2018 |
Mrs Sasha Beresford Individual · British · DOB 10/1970 · age 56 | 25–50% | — | 25-50% shares | 27/03/2018 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · BA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ANDREW MCBRIDE LIMITED→ 11878164 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| AUTISM ALPHABET LIMITED→ 13762601 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AXE MEDICAL LTD→ 11525554 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| B & E HASTINGS LTD→ 14691118 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| BATH & AVON EAR CARE LTD→ 12919381 · est 2020 | — | — | — | — | 5y | — | — |
| BATH HEARING SERVICES LTD→ 14977195 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| BATH HINDU C.I.C.→ 08496251 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| BATH LIVE-IN CARE LTD→ 16966350 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| BATH MIND→ 03531040 · est 1998 · no financials extracted | — | — | — | — | 28y | — | — |
| BATH ORTHODONTICS HOLDINGS LIMITED→ 12501287 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| BATH ORTHODONTICS LIMITED→ 03348763 · est 1997 · no financials extracted | — | — | — | — | 29y | — | — |
| BATH PERFUSION SERVICES LIMITED→ 14531765 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2018-03-27
Jurisdictionengland-wales
Primary SIC86220 — Specialist medical practice activities
Registered office
Willow Court High Street
Bathampton
Bath
BA2 6SY
United Kingdom
Filing status
Accounts
Next due: 2027-12-31
Last made up to: 2026-03-31
Confirmation statement
Next due: 2027-03-12
Last: 2026-02-26
Officers (2 active · 0 resigned)
BERESFORD, Mark, Professor→
Activedirector · ~55y · appointed 2018-03-27
View their other companies + combined net worth →
BERESFORD, Sasha→
Activedirector · ~56y · appointed 2018-03-27
View their other companies + combined net worth →
Click a director name to see their full track record across all companies.
Recent filings (20 total)
accounts-with-accounts-type-micro-entity
accounts · AA
2026-06-29
confirmation-statement-with-updates
confirmation-statement · CS01
2026-03-10
accounts-with-accounts-type-micro-entity
accounts · AA
2025-08-07
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-03-12
accounts-with-accounts-type-micro-entity
accounts · AA
2024-09-23
confirmation-statement-with-updates
confirmation-statement · CS01
2024-03-28
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-11-14
change-person-director-company-with-change-date
officers · CH01
2023-11-14
accounts-with-accounts-type-micro-entity
accounts · AA
2023-08-02
confirmation-statement-with-updates
confirmation-statement · CS01
2023-03-27
legacy
miscellaneous · RPCH01
2022-12-28
accounts-with-accounts-type-micro-entity
accounts · AA
2022-11-21
confirmation-statement-with-updates
confirmation-statement · CS01
2022-04-01
accounts-with-accounts-type-micro-entity
accounts · AA
2021-07-15
confirmation-statement-with-updates
confirmation-statement · CS01
2021-03-26